AI assistant
Cibus, Inc. — Director's Dealing 2018
Jul 2, 2018
34396_dirs_2018-07-02_4602a56b-a027-4c03-95f0-c8fa42ec768a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Calyxt, Inc. (CLXT)
CIK: 0001705843
Period of Report: 2018-06-21
Reporting Person: Dutang Eric (Chief Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 94530 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.5878 | 2026-04-07 | Common Stock (39425) | Direct | |
| Stock Option (Right to Buy) | $13.2939 | 2027-06-14 | Common Stock (147000) | Direct |
Footnotes
F1: Includes 83,300 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017, and remain unvested; 14,700 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months.
F2: The stock option was granted on April 7, 2016. 20% vested on the grant date, 10% vested on the first anniversary of the grant date and an additional 25% vested on completion of the initial public offering by Calyxt, Inc. The remainder vests quarterly in equal 5% installments.
F3: The stock option was granted on June 14, 2017 and vests 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months.